Most Read Articles
06 Jul 2020
Routinely used for treating cardiovascular diseases, statins have been shown to benefit other conditions, and new evidence suggests that using the drug at high intensity reduces the risk of hip or knee replacement, an effect that may be specific to rheumatoid arthritis.
Pearl Toh, 29 Jun 2020
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
Roshini Claire Anthony, 5 days ago

Upadacitinib may be a suitable treatment for patients with active psoriatic arthritis (PsA) who have insufficient response to non-biologic disease-modifying anti-rheumatic drugs (non-bDMARDs), according to results of the phase III SELECT-PsA-1* trial presented at EULAR 2020.

4 days ago
Maternal stress during pregnancy correlates with rapid weight gain of her infant, a recent study has found.

BRCA mutations do not up risk of colorectal cancer

29 Jun 2020

Carriers of the BRCA1 and/or BRCA2 mutation do not appear to be at increased risk of colorectal cancer, according to the results of a recent systematic review and meta-analysis.

The investigators sought to determine the risk of colorectal cancer associated with BRCA carrier mutations. The incidence of colorectal cancer in carriers of BRCA mutation was the primary outcome, while secondary ones included the incidence in BRCA1 and BRCA2 carriers, Ashkenazi Jews, and age- and sex-matched cohorts.

Eleven studies met the eligibility criteria for the systematic review, with an overall population of 14,252 and 4,831 colorectal cancer identified. Of these, only nine studies were included in the meta-analysis.

No increase in incidence of colorectal cancer was observed among patients carrying a BRCA mutation (odds ratio, 1.03, 95 percent confidence interval, 0.80–1.32; p=0.82). There was also no increased likelihood of developing colorectal cancer after adjusting for Ashkenazi heritage and age and sex estimates (with no heterogeneity; I2, 0 percent).

“Carriers of the BRCA1 and/or BRCA2 mutation incur a lifetime risk of up to 85 percent for breast cancer, and between 20 and 40 percent for ovarian cancer,” the investigators noted.

“Efforts to estimate the lifetime risk of developing colorectal cancer for BRCA mutation carriers have produced conflicting results. Consequently, there are no formal guidelines regarding the need for bowel screening for individuals with BRCA1 and/or BRCA2 mutations,” they added.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
06 Jul 2020
Routinely used for treating cardiovascular diseases, statins have been shown to benefit other conditions, and new evidence suggests that using the drug at high intensity reduces the risk of hip or knee replacement, an effect that may be specific to rheumatoid arthritis.
Pearl Toh, 29 Jun 2020
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
Roshini Claire Anthony, 5 days ago

Upadacitinib may be a suitable treatment for patients with active psoriatic arthritis (PsA) who have insufficient response to non-biologic disease-modifying anti-rheumatic drugs (non-bDMARDs), according to results of the phase III SELECT-PsA-1* trial presented at EULAR 2020.

4 days ago
Maternal stress during pregnancy correlates with rapid weight gain of her infant, a recent study has found.